Effector Therapeutics Inc (EFTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 675 | 867 | 2,011 | 0 | 311 |
| Gross Profit | 675 | 867 | 2,011 | N/A | 311 |
| Operating Expenses | 9,398 | 10,118 | 9,892 | 6,548 | 12,713 |
| Operating Income | -8,723 | -9,251 | -7,881 | -6,548 | -12,402 |
| Interest Expense | 698 | 570 | 505 | 478 | 490 |
| Other Income | 161 | 262 | 1,471 | 10,095 | 31,941 |
| Pre-tax Income | -9,260 | -9,559 | -6,915 | 3,069 | 19,049 |
| Net Income Continuous | -9,260 | -9,559 | -6,915 | 3,069 | 19,049 |
| Net Income | $-9,260 | $-9,559 | $-6,915 | $3,069 | $19,049 |
| EPS Basic Total Ops | -5.76 | -5.75 | -4.25 | 2.00 | 222.50 |
| EPS Basic Continuous Ops | -5.63 | -5.80 | -4.20 | 1.88 | 222.39 |
| EPS Diluted Total Ops | -5.51 | -5.75 | -4.25 | 1.75 | 210.00 |
| EPS Diluted Continuous Ops | -5.52 | -5.80 | -4.20 | 1.77 | 209.44 |
| EPS Diluted Before Non-Recurring Items | -5.50 | -5.75 | -4.25 | N/A | N/A |
| EBITDA(a) | $-8,831 | $-9,257 | $-7,805 | $-6,494 | $-12,397 |